News 2021-04-21
2021 Pharmaceutical Crystallization Summit
Breaking Drug Development Bottlenecks via Enabling Technologies
Physical & chemical properties of drug substance (DS) have major impacts on the formulation process & Drug Product (DP) properties or quality attributes. The final step in an API synthesis is usually crystallization or precipitation, serving as both purification and isolation. This international conference gathers industrial and academic subject matter experts to discuss their works related to DS crystallization and manufacturing opportunities (highlighted below)for new drug development programs.
(1) crystal structure prediction, (2) crystal shape prediction, (3) solubility assessment, (4) purification, and (5) analytical technologies
(1) co-processed API’s, (2) process intensification, (3) additive manufacturing, (4) adv. process control & automation, (5)modular systems
Please Click the image below to see more details.
Others
More
News 2026-09-01
Porton to Showcase End-to-End CDMO Expertise at CPHI Milan 2026
CPHI creates connections and inspires partnerships across the global pharma community, championing innovation at the heart of pharma through in-person and online events that grant access to endless opportunities.

News 2026-08-31
Porton Newsletter - August 2026 Recap
Porton Newsletter - August 2026 Recap
